The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance
Open accessAbstract
BACKGROUND: Insulin resistance and impaired insulin secretion both occur in non-insulin-dependent diabetes (NIDDM), but their relative importance is unclear. Hyperglycemia itself has adverse effects on tissue insulin sensitivity and insulin secretion that make it difficult to distinguish between primary and secondary abnormalities. To avoid this problem we studied subjects with postprandial glucose intolerance but not sustained hyperglycemia. METHODS: We compared the rate of systemic appearance and disappearance of glucose, the output of endogenous hepatic glucose, splanchnic and muscle uptake of glucose, and plasma insulin and glucagon responses after the ingestion of 1 g of glucose per kilogram of body weight in 15 subjects with impaired glucose tolerance (8 of them nonobese and 7 obese) and in 16 normal subjects (9 nonobese and 7 obese) who were matched for age and weight. RESULTS: After glucose ingestion the mean (+/- SE) rate of total systemic appearance of glucose was significantly higher in both the nonobese subjects (455 +/- 12 mmol per five hours) and the obese subjects (486 +/- 17 mmol per five hours) with impaired glucose tolerance than in the respective normal subjects (411 +/- 11 and 436 +/- 7 mmol per five hours). This difference was fully accounted for by the reduced suppression of endogenous hepatic glucose in the subjects with impaired glucose tolerance (a reduction of about 28 percent, vs. 48 percent in the normal subjects; P less than 0.01). Despite late hyperinsulinemia, at 30 minutes the subjects with impaired glucose tolerance had smaller increases in plasma insulin and smaller reductions in plasma glucagon (both P less than 0.01). Molar ratios of plasma insulin to plasma glucagon levels correlated inversely (r = -0.62, P less than 0.001) with the rates of systemic glucose appearance; the latter correlated positively (r = 0.72, P less than 0.0001) with peak plasma glucose concentrations. CONCLUSIONS: Impaired glucose tolerance, the precursor of NIDDM, results primarily from reduced suppression of hepatic glucose output due to abnormal pancreatic islet-cell function. The late hyperinsulinemia may be the consequence of an inadequate early beta-cell response rather than of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“As indicated by several studies, insulin resistance leads to basal-fasting hyperinsulinemia, which may result in the insensitivity of beta-cell secretion. This insensitivity leads to a lower first-phase insulin secretion to the rising postprandial glucose but a subsequent exaggerated compensatory second-phase insulin secretion, which might result in hypoglycemia [2, 3].”
From Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population (2017) · cites this paper as [3]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When the first-phase insulin response decreases, firstly, blood glucose starts to rise after the meal, which leads to late but excessive secretion of the second-phase insulin secretion. Thus, late reactive hypoglycemia occurs.[3]”
From Postprandial Reactive Hypoglycemia (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredIn the citing paper
“Indeed, with better matching of subjects for age, sex and obesity, there also does seem to be a decrease of the insulinogenic index in subjects with IGT [5, 87, 88].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [5]
In the citing paper
“This reduction in the early insulin response results in a lack of adequate suppression of hepatic glucose production with subsequent post challenge hyperglycaemia and increased insulin concentrations late in the test [5, 126].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807
Rossetti, L., Giaccari, A., & DeFronzo, R. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.610 · Cited by 774
Kolterman, O., Gray, R. S., Griffin, J., BURSTEIN, P. J., Insel, J. R., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 628
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578
METHODS FOR THE INVESTIGATION OF PERIPHERAL BLOOD FLOW
Greenfield, A. D. M., Whitney, R. J., & Mowbray, J. F. (1963) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070026 · Cited by 494
Andres, R., Cader, G., & Zierler, K. L. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103324 · Cited by 389
Glucagon physiology and pathophysiology in the light of new advances
Unger, R. H. (1985) · Diabetologia · doi:10.1007/bf00281991 · Cited by 361
Research works printed but not linked: 6
- Gerich, 1988, Clin Endocrinol Metab, 2, 307
- Luzi, 1989, Am J Physiol, 257, E241
- 1980, WHO Tech Rep Ser, 646, 1
- Faloona GR, Unger RH. Glucagon. In: Jaffe BM, Behrman HR, eds. Methods of hormone radioimmunoassay. New York: Academic Press, 1974:317–30
- Hetenyi, 1974, Fed Proc, 33, 1841
- Chiasson, 1977, Fed Proc, 36, 229
Cited by
Sorted by citations
Items 501–593 of 593
Lin, C.-W. (2011) · doi:10.17077/etd.9huqp2h8 · Cited by 2
Cao, Y., & Wang, X. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100392 · Cited by 1
Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis
Perez, K. C., Alexander, J., Rahman, M. M., Alsharif, H. A., Liu, Y., Kim, J., Hunter, C. S., Nguyen, T. M., & Bhatnagar, S. (2026) · Diabetes · doi:10.2337/db25-0644 · Cited by 1
Organelle proteomics of human, neonatal pig, healthy and diabetic mouse islets
Çalışkan, Ö. Ş., Haas, D. T., Ferreira, J. V., Chubanava, S., Kemter, E., Cota, P., Bastidas-Ponce, A., Tarquis-Medina, M., Czarnecki, O., Bhattacharya, S., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117751 · Cited by 1
Molecular Mechanism Underlying the Intra-Islet Regulation of Glucagon Secretion
Kawamori, D., & Rohit, N. K. (2011) · InTech eBooks · doi:10.5772/24792 · Cited by 1
ALFORD, F. P., Rantzau, C., Henriksen, J. E., Egede, M. B., Durck, T. T., Levin, K., & Beck‐Nielsen, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1644 · Cited by 1
Kondo, Y., Harada, N., Sozu, T., Hamasaki, A., Yamane, S., Muraoka, A., Harada, T., Shibue, K., Nasteska, D., Joo, E., et al. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.05.013 · Cited by 1
Diabetes in South African Indians : editorial
Omar, M. A. K. (2008) · The South African journal of diabetes & vascular disease · Cited by 1
Watve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_2 · Cited by 1
Hypoglycemia and Hypoglycemic Syndromes
Davis, S. N. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00047-2 · Cited by 1
Alsahli, M., & Gerich, J. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_2-1 · Cited by 1
Self-citationFormen der Insulintherapie bei Typ-2-Diabetes
Liebl, A. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0886-1 · Cited by 1
Prediabetes - The New Target for Primary Prevention of Cardiovascular Metabolic Dysfunction
Afzan, E., Ahmad, R., Lim, B. T. X., Amudha, K., Hussain, R., Azman, W., Ahmad, W., Ismail, I. S., Choy, A. M., & Lang, C. C. (2005) · Cited by 1
Is HbA1c level affected by high triglyceride levels?
Araç, E., & Solmaz, İ. (2020) · Ortadoğu Tıp Dergisi · doi:10.21601/ortadogutipdergisi.715645 · Cited by 1
Ko, Y., Shin, S. H., Mun, S., Kim, D. H., Lim, S. J., Jung, C. H., Kwon, H., Jung, J. H., Kim, Y. H., & Han, D. J. (2021) · Pancreas · doi:10.1097/mpa.0000000000001800 · Cited by 1
CASE SERIES OF REACTIVE HYPOGLYCEMIA
Varughese, M., & Anjali, R. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/5101660 · Cited by 1
Wu, T., Liao, E., Chen, Y., Lin, Y., Liu, S., Lin, H., Chiu, Y., Wu, C., Lin, J., Pei, D., et al. (2022) · Journal of International Medical Research · doi:10.1177/03000605221115161 · Cited by 1
Ong, K. T. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Does Impaired Glucose Tolerance Really Exist, and if so What Should be Done About it?
Nolan, J. J., & Murphy, E. (2001) · Wiley eBooks · doi:10.1002/9780470757109.ch2 · Cited by 1
Schiel, K. A. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00142-1 · Cited by 1
Syndrome X and diabetes: What is the mystery?
Weiswasser, J. M., Nylén, E., Arora, S., Wakefield, M., & Sidawy, A. N. (2002) · Seminars in Vascular Surgery · doi:10.1016/s0895-7967(02)70021-5 · Cited by 1
Glucemia posprandial y riesgo cardiovascular
del Cañizo-Gómez, F. J., & Moreira-Andrés, M. N. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)71043-3 · Cited by 1
Hyperinsulinemia in glucose intolerance: Is it true?
Giugliano, D., Quatraro, A., Acampora, R., Rosa, N. D., Ceriello, A., & D'Onofrio, F. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347725 · Cited by 1
Alvarsson, M., Wajngot, A., Efendić, S., & Grill, V. (1995) · Acta Diabetologica · doi:10.1007/bf00569563 · Cited by 1
Cruz, N. S., Sartori, M. S., dos Santos, M. L., Aragon, F. F., Padovani, C. R., & Pimenta, W. P. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000200008 · Cited by 1
Demographic and metabolic characteristics of individuals with progressive glucose tolerance
Mendes, A. L., dos Santos, M. L., Padovani, C. R., & Pimenta, W. P. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009000300009 · Cited by 1
[Physiopathology of post-prandial hyperglycemia].
Scheen, A. J., & Paquot, N. (2006) · PubMed · Cited by 1
Hussain, K., & Dunne, M. J. (2005) · Clinical Pediatric Endocrinology · doi:10.1002/9780470987117.ch22 · Cited by 1
The Role of ER Stress and the Unfolded Protein Response in Obesity Associated Type 2 Diabetes
Omikorede, O. (2012) · Leicester Research Archive (University of Leicester) · Cited by 1
Hypoglycemia: Assessment and Management
Cotterill, A. M., Cowley, D. M., & Greer, R. M. (2009) · doi:10.1002/9781444316728.ch19
Filho, M. A. D. S. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2008.tde-16032009-153306
Yan, H., Gu, W., & Véniant, M. M. (2011) · doi:10.1002/9780470910016.ch17
Sarı, A., Bozkurt, M., & Halifeoğlu, İ. (2015) · NWSA Academic Journals · doi:10.12739/nwsa.2015.10.2.3a0071
Takada, J. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2008.tde-04082008-130026
Exploring the Grey Zone between Type 1 and Type 2 Diabetes
Bakhtadze, E. (2009) · Lund University Publications (Lund University)
Bolusani, H. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Redefining treatment choice in type 2 diabetes
Standl, E. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00146-5
Répercussions de l'agression sur le métabolisme et la composition corporelle chez l'individu obèse
Schütz, Y., & Chioléro, R. L. (1998) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(98)80074-5
Nutrition Support of the Diabetic Patient
Sunyecz, L. A., Cicci, A. J., & Mirtallo, J. M. (1973) · Clin-Alert · doi:10.1177/006947707301100128
Lichiardopol, R., & Mirodon, Z. (2000) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2000.tb00127.x
Sakuma, M., Sasaki, M., Katsuda, S., Kobayashi, K., Takaya, C., Umeda, M., & Arai, H. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.13-104
Thiazolidinediones on Insulin Resistance and Insulin Secretion in Obese Diabetic OLETF Rats
Noh, J.-H., Hong, S.-H., Lee, K.-H., Min, K.-M., Yang, T.-Y., Lee, M.-S., Kim, K.-W., & Lee, M. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.1.33
INSILICO DOCKING ANALYSIS OF KAEMPHEROL AND LUTEOLIN AGAINST DIABETIC DRUG TARGET PEPCK1
Ebenezer, A. J. A. D. G. A. I. (2014) · International Journal of Pharma and Bio Sciences
T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate
Fukushima, G., Loh, K., Galić, S., Fam, B. C., Shields, B., Wiede, F., Tremblay, M. L., Watt, M. J., Andrikopoulos, S., & Tiganis, T. (2010)
Diabetes in China 3 Early therapy for type 2 diabetes in China
Yang, W., & Key, G. P. (2014)
Etiologie et physiopathologie du diabète de type 2.
Scheen, A. J., Paquot, N., & Lefevre, P. A. (1995) · ORBi (University of Liège) · doi:10.1016/s1155-1941(19)30205-7
Fast-to-fed shift in glucose homeostasis: clues to an earlier detection of human prediabetic states
Patarrão, R. S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Von einfach bis flexibel — zur Auswahl stehen drei Strategien
Liebl, A. (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-1298-2
Aus der Medizinischen Klinik und Poliklinik I der
München, L.-M.-U., & Steinbeck, G. (2002)
Formen der Insulintherapie bei Typ-2-Diabetes
Liebl, A. (2013) · CME · doi:10.1007/s11298-013-0211-3
Development and evaluation of a novel insulin analogue
Khedkar, A. (2015)
Insights into the metabolic regulation of insulin secretion using a metabolomics approach
Huang, M. (2014) · UWSpace (University of Waterloo)
朋子, 中., & 岩本安彦 (2003) · 糖尿病 · doi:10.11213/tonyobyo1958.46.907
Assessment of putative risk factors in the development of Diabetic Retinopathy in Wales
Chowdhury, S. R. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Examining the Role of Endoplasmic Reticulum Stress in Pancreatic Beta-cell Biology
Teodoro, T. (2012) · TSpace (University of Toronto)
Non-Immune Islet beta cell susceptibility to failure in NODk mice
Hussain, A. H. (2017) · ANU Open Research (Australian National University) · doi:10.25911/5d67b4a4d618c
Kim, Y.-T., Jo, Z.-D., Pang, H.-M., Paek, C.-O., & Mun, C.-S. (2020) · Current Nutrition & Food Science · doi:10.2174/1573401313666170920154311
Prediction of type 2 diabetes: A natural history perspective
B.L., B. L. N. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497503
Von einfach bis flexibel — zur Auswahl stehen drei Strategien: Insulintherapie bei Typ-2-Diabetes
Liebl, A. (2012) · MMW - Fortschritte der Medizin
A prandialis glükózkontroll elérése gyors aszpart inzulinnal
Kis, J. T. (2020) · Diabetologia Hungarica · doi:10.24121/dh.2020.8
Faster Insulin Aspart - a new prandial insulin analogue
Flekač, M. (2017) · Vnitřní lékařství · doi:10.36290/vnl.2017.138
Praveen, E. P., Chouhan, S., Sahoo, J., Khadgawat, R., Khurana, M. L., Gupta, N., Dwivedi, S. N., & Kulshreshtha, B. (2021) · Cureus · doi:10.7759/cureus.15056
Trout, K. K., & Dolin, C. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818902-3.00005-1
Alsahli, M., Shrayyef, M. Z., & Gerich, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_2-2 · Cited by 1
Self-citationPancreas Gland Testing (Hypoglycemia and Diabetes)
(2009) · CRC Press eBooks · doi:10.1201/9781420079364.ch4
Gerich, J. E., Wittlin, S. D., & Meyer, C. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_2
Self-citationHert, S. G. D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734529586.793559018
Nutrition Support of the Diabetic Patient
Sunyecz, L. A., Cicci, A. J., & Mirtallo, J. M. (1992) · Journal of Pharmacy Practice · doi:10.1177/089719009200500508
100 anni dopo l’insulina: cosa ancora non sappiamo della sua secrezione nel diabete di tipo 2
Giuseppe, G. D., Mezza, T., Cinti, F., & Giaccari, A. (2022) · il Diabete · doi:10.30682/ildia2201c
Behera, K. K., Soren, U. K., & Devi, S. (2022) · Journal of Case Reports · doi:10.17659/01.2022.0012
The Impact Of Dietary Advanced Glycation Endproducts
Linkens, A. M. A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20221005al
Therapeutic peptidomimetics in metabolic diseases
Sirhan, W., & Piran, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820141-1.00023-6
Trimethylamine N-oxide impairs β-cell function and glucose tolerancePreprint
Kong, L., Zhao, Q., Jiang, X., Jiang, Q., Li, S., peng, X., Wang, S., Chen, Y., Hou, S., Liu, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2465481/v1
Meng, F., Abisheganaden, J. A., Ang, G. Y., Kannapiran, P., Yap, M. M. C., Lee, S. Y., Leow, M. K., & Lim, C. L. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0703
Pathogenesis of Type 2 Diabetes
Cusi, K. J., & DeFronzo, R. A. (2001) · Comprehensive physiology · doi:10.1002/j.2040-4603.2001.tb01483.x
ZEMB, P. A., & Joulia, F. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6068352
Modifiable Factors Affecting the Postprandial Glycemic Response
Wu, Y., McLaughlin, T., Gorgani, S., Scheideman, A. F., Shao, M. M., Hislop, B. D., Hoang, K., Perelman, D., McGinity, C., Rodgar, M., et al. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261418614 · Cited by 2
Dédifférenciation de la cellule bêta pancréatique humaine
Diedisheim, M. (2017) · theses.fr (ABES) · doi:10.70675/9c2e56d4za035z4fa3zafa6z7786e388a812
Peled, T., Ben-Ami, T., Helman, S., Lando, M. B., Grisaru‐Granovsky, S., & Rottenstreich, M. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70998
Sobel, D. O., & Parmar, K. (2026) · OBM Transplantation · doi:10.21926/obm.transplant.2602269
Akamatsu, Y., Anno, T., Murakami, K., Wada, J., Kaneto, H., & Kamei, S. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7270-26
González‐Vidal, T., Rojo‐Martínez, G., Valdés, S., García‐Escobar, E., Franch‐Nadal, J., Calle-Pascual, A., Castaño, L., Chaves, F. J., Montanya, E., Villa-Fernández, E., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70951
Wang, G. (2026) · Advances in Differential Equations and Control Processes · doi:10.59400/adecp4390
Isobe, H., Anno, T., Kawasaki, F., Kaku, K., & Kaneto, H. (2026) · Diabetology International · doi:10.1007/s13340-026-00927-0
Srinivasan, B. T. (2011) · Leicester Research Archive (University of Leicester)
Feghali, M. N., Driggers, R. W., Miodovnik, M., & Umans, J. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386007-1.00016-7
Metadata
- Authors
- Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J.
- Affiliations
- University of Pittsburgh (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-01-02
- Volume
- 326
- Issue
- 1
- Pages
- 22-29
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2330273698
- Cited by
- 595
- References
- 47
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 13 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 12 · 2015: 27 · 2014: 25 · 2013: 18 · 2012: 19
- FWCI
- 21.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r37dk020411-19)
- National Institute of Diabetes and Digestive and Kidney Diseases (5R37 DK20411)
- National Center for Research Resources (M01RR000056, 5 M01 RR00056)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- impaired glucose tolerance, type 2 diabetes, hepatic glucose production, insulin secretion, hyperinsulinemia, glucagon, insulin/glucagon ratio, muscle glucose uptake, obesity, beta-cell dysfunction, insulin resistance
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucagon, Glucose Tolerance Test, Humans, Insulin, Islets of Langerhans, Liver, Male, Middle Aged, Muscles, Prediabetic State
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
